Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Is Low Dose Combination Therapy Effective for Migraine Prophylaxis ? A Case Series Study

Sina Karamimagham 1 , Tahereh Poursadeghfard 2 and Maryam Poursadeghfard 3 , *
Authors Information
1 Department of Pediatrics, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
2 Department of Statistics, Islamic Azad University, Firooz Abad Branch, Fars, Iran
3 Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: October 2016, 18 (10); e3804
  • Published Online: October 8, 2016
  • Article Type: Research Article
  • Received: August 9, 2015
  • Revised: November 8, 2015
  • Accepted: September 24, 2016
  • DOI: 10.17795/zjrms-3804

To Cite: Karamimagham S, Poursadeghfard T, Poursadeghfard M. Is Low Dose Combination Therapy Effective for Migraine Prophylaxis ? A Case Series Study, Zahedan J Res Med Sci. 2016 ; 18(10):e3804. doi: 10.17795/zjrms-3804.

Copyright © 2016, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Methods and Patients
3. Results
4. Discussion
  • 1. Silberstein SD, Dodick D, Freitag F, Pearlman SH, Hahn SR, Scher AI, et al. Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy. Headache. 2007; 47(4): 585-99[DOI][PubMed]
  • 2. Pascual J. Recent advances in the pharmacological management of migraine. F1000 Med Rep. 2009; 1(39)
  • 3. Kelman L. Migraine changes with age: IMPACT on migraine classification. Headache. 2006; 46(7): 1161-71[DOI][PubMed]
  • 4. Bahrami P, Zebardast H, Zibaei M, Mohammadzadeh M, Zabandan N. Prevalence and characteristics of headache in Khoramabad, Iran. Pain Physician. 2012; 15(4): 327-32[PubMed]
  • 5. Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, et al. Effect of preventive (  blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. Bmj. 2010; 341: 4871[DOI]
  • 6. Zencirci B. Comparison of the effects of dietary factors in the management and prophylaxis of migraine. J Pain Res. 2010; 3: 125-30[PubMed]
  • 7. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007; 68(5): 343-9[DOI][PubMed]
  • 8. Diener HC, Agosti R, Allais G, Bergmans P, Bussone G, Davies B, et al. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2007; 6(12): 1054-62[DOI][PubMed]
  • 9. Pascual J, El Berdei Y, Gomez-Sanchez JC. How many migraine patients need prolonged (>1 year) preventive treatment? Experience with topiramate. J Headache Pain. 2007; 8(2): 90-3[DOI][PubMed]
  • 10. Pompili M, Serafini G, Innamorati M, Serra G, Dominici G, Fortes-Lindau J, et al. Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat Outcome Meas. 2010; 1: 107-18[DOI][PubMed]
  • 11. Modi S, Lowder DM. Medications for migraine prophylaxis. Am Fam Physician. 2006; 73(1): 72-8[PubMed]
  • 12. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol. 2006; 13(6): 560-72[DOI][PubMed]
  • 13. Krymchantowski AV, da Cunha Jevoux C, Bigal ME. Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders. J Headache Pain. 2012; 13(1): 53-9[DOI][PubMed]
  • 14. Headache Classification Subcommittee of the International Headache Society. 2004; 24: 8-160
  • 15. Pain Rating Scale. The British Pain Society [internet]. Charity no. 1103260. 2006;
  • 16. Boes CJ, Capobianco DJ, Cutrer FM, Dodick DW, Garza I, Swanson JW. Headache and other craniofacial pain. In: Bradley WJ, Daroff RB, Fenichel GM, Jankovic J, eds. Neurology in clinical practice. 2008; : 2037-8
  • 17. Gobel H. Botulinum toxin in migraine prophylaxis. J Neurol. 2004; 251 Suppl 1-11[DOI][PubMed]
  • 18. Sullivan E, Bushnell C. Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep. 2010; 14(5): 376-84[DOI][PubMed]
  • 19. Dekker F, Knuistingh Neven A, Andriesse B, Kernick D, Reis R, Ferrari MD, et al. Prophylactic treatment of migraine; the patient's view, a qualitative study. BMC Fam Pract. 2012; 13: 13[DOI][PubMed]
  • 20. Loj J, Solomon GD. Migraine prophylaxis: who, why, and how. Cleve Clin J Med. 2006; 73(9): 793-4-800-1 passim[PubMed]
  • 21. Cady R, Schreiber C. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Headache. 2008; 48(6): 900-13[DOI][PubMed]
  • 22. Pringsheim T, Davenport WJ, Becker WJ. Prophylaxis of migraine headache. CMAJ. 2010; 182(7): 269-76[DOI][PubMed]
  • 23. Kol CM, Dekker F, Neven AK, Assendelft WJ, Blom JW. Acceptance or rejection of prophylactic medicine in patients with migraine: a cross-sectional study. Br J Gen Pract. 2008; 58(547): 98-101[DOI][PubMed]
  • 24. Garza I, Swanson JW. Prophylaxis of migraine. Neuropsychiatr Dis Treat. 2006; 2(3): 281-91[PubMed]
  • 25. Domingues RB, Silva AL, Domingues SA, Aquino CC, Kuster GW. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. Arq Neuropsiquiatr. 2009; 67(4): 973-7[PubMed]
  • 26. Bigal ME, Krymchantowski AV. Emerging drugs for migraine prophylaxis and treatment. MedGenMed. 2006; 8(2): 31[PubMed]
  • 27. Dib M. Optimizing prophylactic treatment of migraine: Subtypes and patient matching. Ther Clin Risk Manag. 2008; 4(5): 1061-78[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments